Search

In 29 pregnancies complicated by maternal diabetes mellitus paired samples of umbilical venous blood were obtained at cordocentesis and delivery to investigate the effect of delivery on indices of fetal oxygenation. After delivery by elective Caesarean section the median umbilical venous blood pH was significantly lower than predelivery, however, there was no significant change in the median umbilical venous blood pO2 or plasma erythropoietin concentration. In those delivered after labour the median umbilical venous blood pH and pO2 were significantly lower and the median plasma erythropoietin concentration was significantly higher than predelivery. The data of this study demonstrate that umbilical venous blood pH and pO2 and plasma erythropoietin are influenced by the mode of delivery and results obtained at delivery may not accurately reflect in utero homeostasis.

Our purpose was to investigate the relationship between fetal pancreatic beta-cell function and fetal acidemia and macrosomia in pregnancies complicated by maternal diabetes mellitus.A cross-sectional study at the Harris Birthright Research Centre for Fetal Medicine, London, was performed. In 32 pregnancies complicated by maternal diabetes mellitus cordocentesis was performed at 36 to 39 weeks' gestation for the measurement of umbilical venous blood pH, PO2, PCO2, lactate, and glucose concentration; plasma insulin immunoreactivity; and insulin/glucose ratio. A reference range for plasma insulin and insulin/glucose ratio was constructed by studying fetal blood samples from 80 women who did not have diabetes mellitus.Mean umbilical venous blood pH was significantly lower and plasma insulin immunoreactivity and insulin/glucose ratio were significantly higher than the appropriate normal mean for gestation. There were significant associations between (1) maternal and fetal blood glucose concentrations (r = 0.95, p0.0001), (2) fetal blood glucose and plasma insulin immunoreactivity (r = 0.57, p0.01), (3) fetal plasma insulin immunoreactivity and blood pH (r = -0.39, p0.05), and (4) fetal insulin/glucose ratio and degree of macrosomia (r = 0.76, p0.0001).Fetal pancreatic beta-cell hyperplasia is implicated in the pathogenesis of both fetal acidemia and macrosomia.

Objective: Our purpose was to investigate placental and fetal circulation in pregnancies complicated by maternal diabetes mellitus and to relate any changes to fetal blood pH, P O 2 , and hematocrit. Study design: Doppler measurements of both uterine arteries, one umbilical artery, the fetal descending thoracic aorta, and one fetal middle cerebral artery were performed in 65 well-controlled diabetic pregnancies in a cross-sectional study at the Harris Birthright Research Centre for Fetal Medicine, London. In 41 cases cordocentesis was also performed for the measurement of umbilical venous blood pH, P O 2 , and hematocrit. Results: The mean umbilical venous blood pH was significantly lower and the hematocrit significantly higher than the appropriate normal mean for gestation. However, the Doppler indices of the placental and fetal circulations were essentially normal, except in some of the cases complicated by preeclampsia or intrauterine growth retardation. Conclusions: Maternal diabetes mellitus is not associated with abnormalities in Doppler indexes of the placental or fetal circulations.

Objective: Our purpose was to investigate the relationship between fetal plasma erythropoietin concentration and measures of short-term and long-term glycemic control and fetal oxygenation in pregnancies complicated by maternal diabetes mellitus. Study Design: A cross-sectional study was performed at The Harris Birthright Research Centre for Fetal Medicine, London. Cordocentesis was performed in 31 diabetic pregnancies for the measurement of umbilical venous blood pH, Po 2 , Pco 2 , lactate and glucose concentration, erythroblast count, hemoglobin, and plasma erythropoietin concentrations. Results: The mean pH was significantly lower and the Pco 2 , lactate, erythropoietin, hemoglobin, and erythroblast counts were significantly higher than the appropriate normal mean for gestation. There were significant associations betwen (1) fetal erythropoietin and erythroblast count, (2) fetal erythroblast count and hemoglobin, (3) fetal hemoglobin and maternal glycosylated hemoglobin, and (4) maternal glucose and fetal glucose, pH, and lactate. Conclusions: We postulate that maternal hyperglycemia causes fetal hyperglycemia and acidemia. Increased erythropoietin may be caused by tissue hypoxia or hyperinsulinemia. The increase in fetal hemoglobin may be the consequence of increased erythropoiesis, mediated by either erythropoietin or hyperinsulinemia.

OBJECTIVES: Our objectives were to determine in pregnancies complicated by diabetic nephropathy (1) if impedance to flow in the uterine and umbilical arteries is normal and (2) if these fetuses are hypoxemic and acidemic and if they have decreased fetal heart rate variation and Doppler blood flow redistribution. STUDY DESIGN: In a cross-sectional study at the Harris Birthright Research Centre for Fetal Medicine, London, serial assessment of fetal heart rate variation and Doppler velocimetry of the placental and fetal circulations was undertaken in six pregnancies complicated by diabetic nephropathy. In all cases cordocentesis was performed within 24 hours before delivery for the measurement of umbilical venous blood gases. RESULTS: Cordocentesis demonstrated these fetuses to be hypoxemic and acidemic. The fetal heart rate variation was decreased; however, impedance to flow in the uterine artery was normal, and increased impedance to flow in the umbilical artery with evidence of blood flow redistribution was observed in only one case. CONCLUSIONS: Fetal hypoxemia and acidemia in pregnancies complicated by diabetic nephropathy is not a consequence of impaired placental perfusion, and the degree of metabolic derangement may be obscured by the apparent normal growth and failure of these fetuses to demonstrate blood flow redistribution.

OBJECTIVE: The aim of this study was to investigate the relationship between fetal anemia, plasma erythropoietin concentration, and erythroblastosis in red blood cell—isoimmunized pregnancies. STUDY DESIGN: Fetal plasma erythropoietin concentration in umbilical venous blood samples from 68 red blood cell—isoimmunized pregnancies at 18 to 35 weeks' gestation was measured. Measurements were compared with the appropriate reference range with gestation, and associations with blood pH, erythroblast count, and hemoglobin concentration were examined. RESULTS: The mean fetal plasma erythropoietin concentration and erythroblast count in red blood cell—isoimmunized pregnancies were significantly increased only in severe fetal anemia (hemoglobin deficit >7 gm/dl). Furthermore, some severely anemic fetuses were hydropic and acidemic. The degree of increase in plasma erythropoietin was significantly associated with both fetal acidemia and, more strongly, fetal erythroblastosis. CONCLUSION: These findings suggest that in fetuses from red blood cell—isoimmunized pregnancies the ability to prevent tissue hypoxia is present until anemia becomes severe, presumably by an increase in cardiac output and tissue perfusion. In severe anemia tissue hypoxia occurs, and the data indicate that fetuses respond by increasing erythropoietin production from at least 20 weeks' gestation. Furthermore, more accurate assessment of tissue oxygenation may be obtained by measuring the erythroblast count rather than the blood pH.

1. Koss LG. The Papanicolaou test for cervical cancer detection. JAMA 1989;261 :737-43. 2. McIndoe WA, McLean MR, Jones R, Mullins PRo The invasive potential of carcinoma in situ of the cervix. Obstet Gynecol 1984;64:451-9. 3. Cartier R. Practical colposcopy. Basel: S Karger, 1977: 106-7. 4. Prendiville W, Davies R, Berry PJ. A low voltage diathermy loop for taking cervical biopsies: a qualitative comparison with punch biopsy forceps. Br J Obstet Gynaecol 1986;93: 1054-60. 5. De Haan RW, Kenemans P. Diathermic stripping of cervicallesions. Eur J Gynecol Oncol 1982;3:268-9. 6. Van Nagell JR, Praker JC. Hicks LP, Conrad R, England G. Diagnostic and therapeutic efficacy of cervical conization. AMJ OBSTET GYNECOL 1976;124:134-40. 7. Burghardt E, Holzer E. Treatment of carcinoma in situ: evaluation of 1609 cases. Obstet Gynecol 1980;55:53946. 8. Benedet JL, Anderson GH, Simpson ML, Shaw D. Colposcopy, conization and hysterectomy practices: a current perspective. Obstet Gynecol 1982;60:539-46. 9. Benedet JL, Miller DM, Nickerson KG, Anderson GH. Diathermy loop exciSion in cervical intraepithelial neoplasia